InMed Pharmaceuticals Inc (INM)
US$ 4.59-3.16%
Price Chart
Key Statistics
Market Cap
$ 3.28M
P/E Ratio
0.00
Revenue (TTM)
$ 4.83M
Volume
9.52K
52W High
$ 9.38
52W Low
$ 1.72
Dividend Yield
0.00%
Beta
0.55
Technicals
50-Day MA
2.7303
200-Day MA
4.3093
52 Week High
9.376
52 Week Low
1.72
About INM
InMed Pharmaceuticals Inc., a clinical stage pharmaceutical company, develops a pipeline of prescription-based products in the United States.
Employees
13
Headquarters
Vancouver, BC
CEO
Mr. Eric A. Adams B.S. Chem., M.I.B.
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg